Explore the preclinical research catching our eye in October 2026, from AI drug design to small molecules and gene therapy ...

Three big bets in metabolic disease: the race to challenge Lilly and Novo, a pill that mimics exercise, and a gene therapy ...

The companies ADARx Pharmaceuticals, Electra Therapeutics, and Enveda bagged the biggest biotech funding rounds overall in ...

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

Known for its freezing winters, Finland is warming up to global entrepreuners and investors to boost its life science ...

Delve into the strategy of Viatris, a company that built its reputation around generics and is steadily moving beyond to find ...

Look into Spain's biotech, an ecosystem that has matured and transforms promissing science into ventures but faces challenges ...

September is often a strong month for the biopharma sector as the industry returns from the summer lull, keen on forging biotech deals.

Merck’s new BioReliance® Facility in Darmstadt, Germany, will support biologics testing, GMP release testing and stability ...

Artificial intelligence (AI) has taken the biotech industry by storm, leading to numerous AI drug discovery companies operating in the field, as the technology enables them to speed up the drug ...

Keep up with biotech layoffs in 2026! Each week, the Labiotech team tracks and analyzes layoffs across the biotech industry, offering a clear, data-driven view of trends affecting companies, ...